The multifaceted role of the stroma in the healthy prostate and prostate cancer
- PMID: 39238004
- PMCID: PMC11378418
- DOI: 10.1186/s12967-024-05564-2
The multifaceted role of the stroma in the healthy prostate and prostate cancer
Abstract
Prostate cancer (PC) is an age-related disease and represents, after lung cancer, the second cause of cancer death in males worldwide. Mortality is due to the metastatic disease, which mainly involves the bones, lungs, and liver. In the last 20 years, the incidence of metastatic PC has increased in Western Countries, and a further increase is expected in the near future, due to the population ageing. Current treatment options, including state of the art cancer immunotherapy, need to be more effective to achieve long-term disease control. The most significant anatomical barrier to overcome to improve the effectiveness of current and newly designed drug strategies consists of the prostatic stroma, in particular the fibroblasts and the extracellular matrix, which are the most abundant components of both the normal and tumor prostatic microenvironment. By weaving a complex communication network with the glandular epithelium, the immune cells, the microbiota, the endothelium, and the nerves, in the healthy prostatic microenvironment, the fibroblasts and the extracellular matrix support organ development and homeostasis. However, during inflammation, ageing and prostate tumorigenesis, they undergo dramatic phenotypic and genotypic changes, which impact on tumor growth and progression and on the development of therapy resistance. Here, we focus on the characteristics and functions of the prostate associated fibroblasts and of the extracellular matrix in health and cancer. We emphasize their roles in shaping tumor behavior and the feasibility of manipulating and/or targeting these stromal components to overcome the limitations of current treatments and to improve precision medicine's chances of success.
Keywords: Ageing population; Desmoplasia; Extracellular matrix; Prostate cancer progression; Prostate cancer-associated fibroblasts; Tumor microenvironment.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.Clin Cancer Res. 2002 Sep;8(9):2912-23. Clin Cancer Res. 2002. PMID: 12231536
-
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer.Nat Rev Urol. 2024 May;21(5):258-273. doi: 10.1038/s41585-023-00827-x. Epub 2023 Oct 31. Nat Rev Urol. 2024. PMID: 37907729 Free PMC article. Review.
-
Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.J Urol. 2005 Jan;173(1):10-20. doi: 10.1097/01.ju.0000141582.15218.10. J Urol. 2005. PMID: 15592017 Review.
-
Asporin is a stromally expressed marker associated with prostate cancer progression.Br J Cancer. 2017 Mar 14;116(6):775-784. doi: 10.1038/bjc.2017.15. Epub 2017 Feb 2. Br J Cancer. 2017. PMID: 28152543 Free PMC article.
-
Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.Int J Mol Med. 2006 Nov;18(5):941-50. Int J Mol Med. 2006. PMID: 17016625
Cited by
-
Anti-cancer role of curcumin in prostate cancer cells via regulation of m6A-modified circ0030568-FMR1 signaling pathway.Transl Androl Urol. 2024 Nov 30;13(11):2358-2375. doi: 10.21037/tau-24-276. Epub 2024 Nov 28. Transl Androl Urol. 2024. PMID: 39698574 Free PMC article.
-
Fibrosis and cancer intersection.J Transl Med. 2025 May 6;23(1):508. doi: 10.1186/s12967-025-06520-4. J Transl Med. 2025. PMID: 40329349 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical